Evidence map›Paper›PMID 17873030›Full record

ArticleJournal of bacteriology2007

Structure and biological activities of beta toxin from Staphylococcus aureus.

Medora Huseby, Ke Shi, C Kent Brown, Jeff Digre, Fikre Mengistu, Keun Seok Seo, Gregory A Bohach, Patrick M Schlievert, Douglas H Ohlendorf, Cathleen A Earhart

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 162 citations in OpenAlex.

  1. Article
  2. Methicillin-resistantiScience · 2026
    Review
  3. Review
  4. Virulence · 2025
    Article
  5. Article
  6. Review
  7. The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implications.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  8. Article
  9. Whole Genome Sequence Analysis of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  10. Infection and immunity · 2025
    Article
  11. Loratadine decreases virulence of methicillin-resistantbioRxiv : the preprint server for biology · 2025
    Article
  12. Cell surface (Amsterdam, Netherlands) · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. β-Hemolysin, notmSphere · 2024
    Article
  18. Microbiology spectrum · 2024
    Article
  19. Beyond the double helix: the multifaceted landscape of extracellular DNA inFrontiers in cellular and infection microbiology · 2024
    Review
  20. Molecular Characteristics and Pathogenicity ofInternational journal of molecular sciences · 2023
    Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Medora HusebyDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota, USA.
Ke Shi
C Kent Brown
Jeff Digre
Fikre Mengistu
Keun Seok Seo
Gregory A Bohach
Patrick M Schlievert
Douglas H Ohlendorf
Cathleen A Earhart
Institute of Molecular Biology and Biophysics · RUUniversity of Idaho · USUniversity of Minnesota · US

Funding

UNDERGRADUATE COLLEGE OUTREACH PROGRAMP20RR016454 · NCRR · UNIVERSITY OF IDAHO · PI CHASE, JENNIFER R · 2001 to 2011
$35.3M
TRANSCRIPTIONAL ATTENUATION OF THE TYPE I INTERFERON RESPONSE BY RHINOVIRUSP20RR015587 · NCRR · UNIVERSITY OF IDAHO · PI BOHACH, GREGORY A · 2000 to 2009
$19.0M
MINNESOTA PAIN RESEARCH TRAINING PROGRAMT32DE007288 · NIDCR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HERZBERG, MARK C · 1996 to 2011
$8.8M
CARDIOTOXICITY OF STREPTOCOCCAL PYROGENIC EXOTOXINSR01HL036611 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI SCHLIEVERT, PATRICK M · 1986 to 2006
$1.3M
Structural Biology of Gram Positive Virulence FactorsR01AI057585 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI EARHART, CATHLEEN A · 2004 to 2008
$1.2M
NCRR NIH HHS P20 RR015587NCRR NIH HHS P20 RR016454NCRR NIH HHS P20 RR15587NHLBI NIH HHS R01 HL036611NHLBI NIH HHS R01 HL36611NIAID NIH HHS R01 AI057585NIAID NIH HHS R01 AI57585NIDCR NIH HHS 5T32-DE007288-11NIDCR NIH HHS T32 DE007288
6 · The paper itself

Abstract

Beta toxin is a neutral sphingomyelinase secreted by certain strains of Staphylococcus aureus. This virulence factor lyses erythrocytes in order to evade the host immune system as well as scavenge nutrients. The structure of beta toxin was determined at 2.4-A resolution using crystals that were merohedrally twinned. This structure is similar to that of the sphingomyelinases of Listeria ivanovii and Bacillus cereus. Beta toxin belongs to the DNase I folding superfamily; in addition to sphingomyelinases, the proteins most structurally related to beta toxin include human endonuclease HAP1, Escherichia coli endonuclease III, bovine pancreatic DNase I, and the endonuclease domain of TRAS1 from Bombyx mori. Our biological assays demonstrated for the first time that beta toxin kills proliferating human lymphocytes. Structure-directed active site mutations show that biological activities, including hemolysis and lymphotoxicity, are due to the sphingomyelinase activity of the enzyme.

Indexed as

Amino Acid SequenceBacterial ToxinsBinding SitesCell ProliferationCells, CulturedDose-Response Relationship, DrugHemolysin ProteinsHumansLymphocytesModels, MolecularMolecular Sequence DataProtein ConformationSphingomyelin PhosphodiesteraseStaphylococcus aureusBacterial ToxinsHemolysin Proteinshlb protein, Staphylococcus aureusSphingomyelin Phosphodiesterase

Identifiers

PMID17873030
PMCPMC2168928
OpenAlexW2108291169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.